Medicure Inc. Reports Downturn in Annual Financials
Medicure Swung to a Loss in 2023 on Lower Sales
Medicure Inc. Unveils 2023 Financial Outcomes
Medicure Inc. GAAP EPS of C$0.03, Revenue of C$5.6M
Medicure Inc. (OTCMKTS:MCUJF) Sees Significant Increase in Short Interest
Medicure Inc. (OTCMKTS:MCUJF) Short Interest Down 66.7% in August
Medicure Inc. Q2 2022 Earnings Call Transcript >MCUJF
BRIEF-Algernon Pharmaceuticals Appoints James Kinley As CFO Effective From December 1, 2021
Press Release: Algernon Pharmaceuticals Announces New Chief Financial Officer
BRIEF-Medicure Updates On Percutaneous Coronary Intervention Study